211 related articles for article (PubMed ID: 21804080)
1. Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.
Kim JS; Werth VP
J Histochem Cytochem; 2011 Aug; 59(8):780-90. PubMed ID: 21804080
[TBL] [Abstract][Full Text] [Related]
2. Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis.
Chang LM; Maheshwari P; Werth S; Schaffer L; Head SR; Kovarik C; Werth VP
J Histochem Cytochem; 2011 Mar; 59(3):336-45. PubMed ID: 21378287
[TBL] [Abstract][Full Text] [Related]
3. Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.
Kim JS; Bashir MM; Werth VP
J Invest Dermatol; 2012 Jul; 132(7):1825-32. PubMed ID: 22456539
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients.
Nabatian AS; Bashir MM; Wysocka M; Sharma M; Werth VP
Arthritis Res Ther; 2012 Jan; 14(1):R1. PubMed ID: 22217359
[TBL] [Abstract][Full Text] [Related]
5. Skin CD4
Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
[TBL] [Abstract][Full Text] [Related]
6. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
Magro CM; Segal JP; Crowson AN; Chadwick P
J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
[TBL] [Abstract][Full Text] [Related]
7. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
[TBL] [Abstract][Full Text] [Related]
8. Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus.
Solé C; Gimenez-Barcons M; Ferrer B; Ordi-Ros J; Cortés-Hernández J
Br J Dermatol; 2016 Aug; 175(2):302-13. PubMed ID: 26972571
[TBL] [Abstract][Full Text] [Related]
9. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
Caproni M; Torchia D; Antiga E; Giomi B; Mercuri M; Volpi W; Fabbri P
J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus.
Király Z; Szepesi Á; Sebestyén A; Kuroli E; Rencz F; Tóth B; Bokor L; Szakonyi J; Medvecz M; Hidvégi B
Pathol Oncol Res; 2022; 28():1610521. PubMed ID: 35979531
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
12. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus.
Denfeld RW; Kind P; Sontheimer RD; Schöpf E; Simon JC
Arthritis Rheum; 1997 May; 40(5):814-21. PubMed ID: 9153541
[TBL] [Abstract][Full Text] [Related]
13. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis.
Grassi M; Capello F; Bertolino L; Seia Z; Pippione M
Clin Exp Dermatol; 2009 Dec; 34(8):910-4. PubMed ID: 19456762
[TBL] [Abstract][Full Text] [Related]
14. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet irradiation induces the accumulation of chondroitin sulfate, but not other glycosaminoglycans, in human skin.
Werth BB; Bashir M; Chang L; Werth VP
PLoS One; 2011; 6(8):e14830. PubMed ID: 21829593
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
[TBL] [Abstract][Full Text] [Related]
17. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus.
Kuhn A; Sonntag M; Lehmann P; Megahed M; Vestweber D; Ruzicka T
Arch Dermatol Res; 2002 Mar; 294(1-2):6-13. PubMed ID: 12071156
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Expression Profiling Identifies miR-31 and miR-485-3p as Regulators in the Pathogenesis of Discoid Cutaneous Lupus.
Solé C; Domingo S; Ferrer B; Moliné T; Ordi-Ros J; Cortés-Hernández J
J Invest Dermatol; 2019 Jan; 139(1):51-61. PubMed ID: 30130620
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in different cutaneous manifestations of lupus erythematosus.
Baima B; Sticherling M
Br J Dermatol; 2001 May; 144(5):958-66. PubMed ID: 11359381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
